46 related articles for article (PubMed ID: 21315144)
1. [Long term maintenance of cytochrome P450 activity in a cell sheet-based three-dimensional human hepatic model].
Guan S; Gao B; Xiao J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Aug; 39(4):776-783. PubMed ID: 36008342
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture system.
Richter M; Fairhall EA; Hoffmann SA; Tröbs S; Knöspel F; Probert PME; Oakley F; Stroux A; Wright MC; Zeilinger K
Toxicol Res (Camb); 2016 Jan; 5(1):278-290. PubMed ID: 30090344
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Physical Cellular Microenvironment on the Structure and Function of a Model Hepatocyte Cell Line for Drug Toxicity Applications.
Allcock B; Wei W; Goncalves K; Hoyle H; Robert A; Quelch-Cliffe R; Hayward A; Cooper J; Przyborski S
Cells; 2023 Oct; 12(19):. PubMed ID: 37830622
[TBL] [Abstract][Full Text] [Related]
4. A 3D Cell Culture Organ-on-a-Chip Platform With a Breathable Hemoglobin Analogue Augments and Extends Primary Human Hepatocyte Functions
Shoemaker JT; Zhang W; Atlas SI; Bryan RA; Inman SW; Vukasinovic J
Front Mol Biosci; 2020; 7():568777. PubMed ID: 33195413
[TBL] [Abstract][Full Text] [Related]
5. A Standardized Collagen-Based Scaffold Improves Human Hepatocyte Shipment and Allows Metabolic Studies over 10 Days.
Ruoß M; Häussling V; Schügner F; Olde Damink LHH; Lee SML; Ge L; Ehnert S; Nussler AK
Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30332824
[TBL] [Abstract][Full Text] [Related]
6. Application of Covalent Binding Body Burden in the HμREL Human Hepatocyte Coculture Model for Reactivity Risk Assessment of Metabolically Low Turnover Drugs.
Shang J; Coe KJ; Lim HK; Chen L; Khatri BB; Salter R; Mitra K; Iyer R
Chem Res Toxicol; 2024 Apr; 37(4):540-544. PubMed ID: 38530825
[TBL] [Abstract][Full Text] [Related]
7. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
[TBL] [Abstract][Full Text] [Related]
8. Microencapsulated Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells: Optimizing 3D Culture for Tissue Engineering Applications.
Hussein M; Pasqua M; Pereira U; Benzoubir N; Duclos-Vallée JC; Dubart-Kupperschmitt A; Legallais C; Messina A
Cells; 2023 Mar; 12(6):. PubMed ID: 36980206
[TBL] [Abstract][Full Text] [Related]
9. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.
Serras AS; Rodrigues JS; Cipriano M; Rodrigues AV; Oliveira NG; Miranda JP
Front Cell Dev Biol; 2021; 9():626805. PubMed ID: 33732695
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine Biotransformation Insights: An Integrated In Vitro Approach Unveils the Biocompetence and
Cipriano M; Pinheiro PF; Sequeira CO; Rodrigues JS; Oliveira NG; Antunes AMM; Castro M; Marques MM; Pereira SA; Miranda JP
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503263
[TBL] [Abstract][Full Text] [Related]
11. Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization.
Ashraf MN; Asghar MW; Rong Y; Doschak MR; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):437-458. PubMed ID: 30535757
[TBL] [Abstract][Full Text] [Related]
12. Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.
Roth AD; Lee MY
Biomed Res Int; 2017; 2017():9176937. PubMed ID: 28133614
[TBL] [Abstract][Full Text] [Related]
13. Novel
Williams DP; Shipley R; Ellis MJ; Webb S; Ward J; Gardner I; Creton S
Toxicol Res (Camb); 2013 Jan; 2(1):40-59. PubMed ID: 26966512
[TBL] [Abstract][Full Text] [Related]
14. Effect of Concentrated Fibroblast-Conditioned Media on In Vitro Maintenance of Rat Primary Hepatocyte.
Jeong D; Han C; Kang I; Park HT; Kim J; Ryu H; Gho YS; Park J
PLoS One; 2016; 11(2):e0148846. PubMed ID: 26863621
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury.
Krueger W; Boelsterli UA; Rasmussen TP
J Clin Transl Hepatol; 2014 Sep; 2(3):143-52. PubMed ID: 26355943
[TBL] [Abstract][Full Text] [Related]
16. Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of
Usta OB; McCarty WJ; Bale S; Hegde M; Jindal R; Bhushan A; Golberg I; Yarmush ML
Technology (Singap World Sci); 2015 Mar; 3(1):1-26. PubMed ID: 26167518
[TBL] [Abstract][Full Text] [Related]
17. In search of suitable in vitro models to study germ cell movement across the blood-testis barrier.
Mruk DD; Cheng CY
Spermatogenesis; 2012 Jan; 2(1):6-10. PubMed ID: 22553485
[TBL] [Abstract][Full Text] [Related]
18. Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications.
Leite SB; Teixeira AP; Miranda JP; Tostões RM; Clemente JJ; Sousa MF; Carrondo MJ; Alves PM
Toxicol In Vitro; 2011 Jun; 25(4):825-32. PubMed ID: 21315144
[TBL] [Abstract][Full Text] [Related]
19. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors.
Miranda JP; Rodrigues A; Tostões RM; Leite S; Zimmerman H; Carrondo MJ; Alves PM
Tissue Eng Part C Methods; 2010 Dec; 16(6):1223-32. PubMed ID: 20184401
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
